Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals IncfiledCriticalIonis Pharmaceuticals Inc
Publication of ECSP21042779ApublicationCriticalpatent/ECSP21042779A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Las presentes modalidades proporcionan métodos, compuestos, y composiciones útiles para inhibir la expresión de IRF5, que pueden ser útiles para tratar, prevenir o mejorar una enfermedad asociada con el IRF5.
ECSENADI202142779A2020-11-152021-06-11Moduladores de la expresión de irf5
ECSP21042779A
(es)